Symbol Lookup

Thursday June 20, 2013 3:21 AM ET. Data delayed 15 minutes.
61.90
-0.55 (-0.88%)
Bid/Lots
59.15/1
Ask/Lots
64.90/1
Open/Prev Close
62.23/62.45
Day Range
61.72-62.85
52-Week Range
41.15-66.52
Vol/Avg Daily Vol
134.2K/332.2K
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
As top court invalidates some gene patents, biotech has moved on
6:59PM ET on Thursday Jun 13, 2013 by Thomson Reuters

By Sharon Begley

NEW YORK, June 13 (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has b...

UPDATE 1-Lilly halts Alzheimer's drug trial due to liver problems
6:27PM ET on Thursday Jun 13, 2013 by Thomson Reuters

By Ransdell Pierson

June 13 (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment...

ANALYSIS-After tech success, Israel seeks life sciences growth
6:50AM ET on Thursday Jun 06, 2013 by Thomson Reuters

By Tova Cohen and Steven Scheer

HERZLIYA, Israel, June 6 (Reuters) - Inspired by its success in high-tech electronics and software, Israel is hoping to...

A New Approach to Treating Cancer
2:49PM ET on Wednesday Jun 05, 2013 by Accesswire

Aethlon Medical CEO Discusses Business Catalysts and New Cancer Treatments in Exclusive Interview on SECFilings.com

There has been no shortage of news in the biotechnology industry in 2013, especially in the cancer space as new therapies...

ANALYSIS-New cancer breakthroughs add pressure to control costs
1:00AM ET on Wednesday Jun 05, 2013 by Thomson Reuters

By Deena Beasley

June 5 (Reuters) - An exciting class of new cancer drugs may boost patients' odds for survival, but healthcare providers and insurers ...

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
Johnson & Johnson JNJ238.4B23.1x+1.22%
Pfizer Inc PFE206.4B20.6x+1.33%
Novartis AG NVS197.5B18.4x+6.79%
GlaxoSmithKline PLC GSK128.1B19.9x-0.47%
Sanofi SA SNY144.7B25.7x-0.79%
Data delayed 15 minutes.

Company Information

Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan.

CONTACT INFORMATION

HeadquartersGrenzacherstrasse 124
Basel, Switzerland 4070
Phone973-235-4295
Fax--

EXECUTIVE OFFICERS

Chairman of the Corporate Executive Committee, Chief Executive OfficerSeverin Schwan
Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology OfficerAlan Hippe
Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research & Early DevelopmentMike Burgess
Member of the Enlarged Corporate Executive Committee, Head Group CommunicationsStephan Feldhaus
Member of the Enlarged Corporate Executive Committee, Head of Roche PartneringSophie Kornowski-Bonnet

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • Standard & Poor's Stock Report

    Standard & Poor's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$216.1BBeta0.71
Revenue (TTM)$49.0BEPS$3.00
Shares Out.3.5BBook Value$4.53
Dividend Yield2.74%P/E20.6x
Annual Dividend Rate$1.69Price/Sales (TTM)4.4
Ex-Div Date3/7/13P/Cash Flow (TTM)16.4x
Pay Date1/1/01Operating Margin30.99%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample